215 related articles for article (PubMed ID: 18972095)
1. Changes in plasma endocannabinoid levels in viscerally obese men following a 1 year lifestyle modification programme and waist circumference reduction: associations with changes in metabolic risk factors.
Di Marzo V; Côté M; Matias I; Lemieux I; Arsenault BJ; Cartier A; Piscitelli F; Petrosino S; Alméras N; Després JP
Diabetologia; 2009 Feb; 52(2):213-7. PubMed ID: 18972095
[TBL] [Abstract][Full Text] [Related]
2. Circulating endocannabinoid levels, abdominal adiposity and related cardiometabolic risk factors in obese men.
Côté M; Matias I; Lemieux I; Petrosino S; Alméras N; Després JP; Di Marzo V
Int J Obes (Lond); 2007 Apr; 31(4):692-9. PubMed ID: 17224929
[TBL] [Abstract][Full Text] [Related]
3. Plasma 2-arachidonoylglycerol is a biomarker of age and menopause related insulin resistance and dyslipidemia in lean but not in obese men and women.
Fanelli F; Mezzullo M; Belluomo I; Di Lallo VD; Baccini M; Ibarra Gasparini D; Casadio E; Mastroroberto M; Vicennati V; Gambineri A; Morselli-Labate AM; Pasquali R; Pagotto U
Mol Metab; 2017 May; 6(5):406-415. PubMed ID: 28462075
[TBL] [Abstract][Full Text] [Related]
4. Visceral and not subcutaneous abdominal adiposity reduction drives the benefits of a 1-year lifestyle modification program.
Borel AL; Nazare JA; Smith J; Alméras N; Tremblay A; Bergeron J; Poirier P; Després JP
Obesity (Silver Spring); 2012 Jun; 20(6):1223-33. PubMed ID: 22262155
[TBL] [Abstract][Full Text] [Related]
5. Role of insulin as a negative regulator of plasma endocannabinoid levels in obese and nonobese subjects.
Di Marzo V; Verrijken A; Hakkarainen A; Petrosino S; Mertens I; Lundbom N; Piscitelli F; Westerbacka J; Soro-Paavonen A; Matias I; Van Gaal L; Taskinen MR
Eur J Endocrinol; 2009 Nov; 161(5):715-22. PubMed ID: 19745037
[TBL] [Abstract][Full Text] [Related]
6. Circulating endocannabinoids in insulin sensitive vs. insulin resistant obese postmenopausal women. A MONET group study.
Abdulnour J; Yasari S; Rabasa-Lhoret R; Faraj M; Petrosino S; Piscitelli F; Prud' Homme D; Di Marzo V
Obesity (Silver Spring); 2014 Jan; 22(1):211-6. PubMed ID: 23616305
[TBL] [Abstract][Full Text] [Related]
7. Improvement in insulin sensitivity following a 1-year lifestyle intervention program in viscerally obese men: contribution of abdominal adiposity.
Borel AL; Nazare JA; Smith J; Alméras N; Tremblay A; Bergeron J; Poirier P; Després JP
Metabolism; 2012 Feb; 61(2):262-72. PubMed ID: 21864868
[TBL] [Abstract][Full Text] [Related]
8. Visceral Adiposity Measurements, Metabolic and Inflammatory Profi le in Obese Patients with and Without Type 2 Diabetes Mellitus: A Crosssectional Analysis.
Wanderley Rocha DR; Jorge AR; Braulio VB; Arbex AK; Marcadenti A
Curr Diabetes Rev; 2017; 13(1):11-18. PubMed ID: 26467189
[TBL] [Abstract][Full Text] [Related]
9. Normalization of visceral adiposity is required to normalize plasma apolipoprotein B levels in response to a healthy eating/physical activity lifestyle modification program in viscerally obese men.
Pelletier-Beaumont E; Arsenault BJ; Alméras N; Bergeron J; Tremblay A; Poirier P; Després JP
Atherosclerosis; 2012 Apr; 221(2):577-82. PubMed ID: 22321874
[TBL] [Abstract][Full Text] [Related]
10. Measures of abdominal obesity assessed for visceral adiposity and relation to coronary risk.
Onat A; Avci GS; Barlan MM; Uyarel H; Uzunlar B; Sansoy V
Int J Obes Relat Metab Disord; 2004 Aug; 28(8):1018-25. PubMed ID: 15197408
[TBL] [Abstract][Full Text] [Related]
11. The decrease in C-reactive protein concentration after diet and physical activity induced weight reduction is associated with changes in plasma lipids, but not interleukin-6 or adiponectin.
Dvoráková-Lorenzová A; Suchánek P; Havel PJ; Stávek P; Karasová L; Valenta Z; Tintĕra J; Poledne R
Metabolism; 2006 Mar; 55(3):359-65. PubMed ID: 16483880
[TBL] [Abstract][Full Text] [Related]
12. Simultaneous postprandial deregulation of the orexigenic endocannabinoid anandamide and the anorexigenic peptide YY in obesity.
Gatta-Cherifi B; Matias I; Vallée M; Tabarin A; Marsicano G; Piazza PV; Cota D
Int J Obes (Lond); 2012 Jun; 36(6):880-5. PubMed ID: 21844878
[TBL] [Abstract][Full Text] [Related]
13. Circulating Endocannabinoids and the Polymorphism 385C>A in Fatty Acid Amide Hydrolase (FAAH) Gene May Identify the Obesity Phenotype Related to Cardiometabolic Risk: A Study Conducted in a Brazilian Population of Complex Interethnic Admixture.
Martins CJ; Genelhu V; Pimentel MM; Celoria BM; Mangia RF; Aveta T; Silvestri C; Di Marzo V; Francischetti EA
PLoS One; 2015; 10(11):e0142728. PubMed ID: 26561012
[TBL] [Abstract][Full Text] [Related]
14. Plasma leptin is independently associated with the intima-media thickness of the common carotid artery.
Ciccone M; Vettor R; Pannacciulli N; Minenna A; Bellacicco M; Rizzon P; Giorgino R; De Pergola G
Int J Obes Relat Metab Disord; 2001 Jun; 25(6):805-10. PubMed ID: 11439293
[TBL] [Abstract][Full Text] [Related]
15. Dysregulation of the peripheral and adipose tissue endocannabinoid system in human abdominal obesity.
Blüher M; Engeli S; Klöting N; Berndt J; Fasshauer M; Bátkai S; Pacher P; Schön MR; Jordan J; Stumvoll M
Diabetes; 2006 Nov; 55(11):3053-60. PubMed ID: 17065342
[TBL] [Abstract][Full Text] [Related]
16. Body adiposity index and other indexes of body composition in the SAPHIR study: association with cardiovascular risk factors.
Melmer A; Lamina C; Tschoner A; Ress C; Kaser S; Laimer M; Sandhofer A; Paulweber B; Ebenbichler CF
Obesity (Silver Spring); 2013 Apr; 21(4):775-81. PubMed ID: 23712981
[TBL] [Abstract][Full Text] [Related]
17. Obesity indices and metabolic markers are related to hs-CRP and adiponectin levels in overweight and obese females.
Sanip Z; Ariffin FD; Al-Tahami BA; Sulaiman WA; Rasool AH
Obes Res Clin Pract; 2013; 7(4):e315-20. PubMed ID: 24306161
[TBL] [Abstract][Full Text] [Related]
18. Caloric restriction lowers endocannabinoid tonus and improves cardiac function in type 2 diabetes.
van Eyk HJ; van Schinkel LD; Kantae V; Dronkers CEA; Westenberg JJM; de Roos A; Lamb HJ; Jukema JW; Harms AC; Hankemeier T; van der Stelt M; Jazet IM; Rensen PCN; Smit JWA
Nutr Diabetes; 2018 Jan; 8(1):6. PubMed ID: 29343706
[TBL] [Abstract][Full Text] [Related]
19. Cardiovascular disease under the influence of excess visceral fat.
Després JP
Crit Pathw Cardiol; 2007 Jun; 6(2):51-9. PubMed ID: 17667865
[TBL] [Abstract][Full Text] [Related]
20. Sex differences in serum leptin and its relation to markers of cardiometabolic risk in middle-aged adults: evidence from a population-based study.
de Castro MA; Baltar VT; Marchioni DM; Fisberg RM
Nutrition; 2015 Mar; 31(3):491-7. PubMed ID: 25701340
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
